Scientists at acib and the University of Natural Resources Vienna develop world’s first continuous purification method for valuable drugs. This will lead to significantly reduced production costs and to cheaper pharmaceuticals that are affordable for non-privileged health care systems.
Imagine a dear relative suffering from cancer – and you could not afford a treatment because the drugs are too expensive. The Austrian Centre of Industrial Biotechnology (acib) developed a method with the power to reduce production costs of highly valued drugs significantly.
Without antibodies we would be at the mercy of pathogens or cancer cells. Therapeutic antibodies are used as passive vaccines, for cancer therapy or for controlling autoimmune diseases such as multiple sclerosis. According to “bccresearch.com” the global market for antibody drugs was worth nearly 70 billion USD in 2014 and should rise to 122 billion USD until 2019.
Two thirds of those molecules are produced biotechnologically using Chinese hamster ovary cells (CHO). Actually the major cost factor for industry is purification using “protein A” affinity chromatography where tens of thousands of liters of culture volume have to be processed annually. About 80 % of the production costs fall upon purification.
Here this new purification method comes into play. Researchers from the Austrian Centre of Industrial Biotechnology (acib) and the University of Natural Resources and Life Sciences Vienna (BOKU) developed the world’s first downstream processing method for recombinant antibodies from clarified CHO cultures. From a technical view, the purification method combines a Calcium-Phosphate flocculation with a subsequent cold ethanol precipitation in a tubular reactor realized as a double-pipe heat exchanger that is operated in counter-current flow.
A feasibility study exemplified by the purification of immune globulin G (IgG) shows that the continuous method can compete with “protein A” affinity chromatography in terms of yield and outperforms chromatography according to the speed of operation. A further advantage is that the operation parameters can be easily transferred from the actually used batch to the continuous approach. In combination with a prior concentration step the new method is perfect for purification of low titer supernatants. “Our method shows great potential as a new platform technology for the pharmaceutical industry”, says Prof. Alois Jungbauer, who is in negotiations with several international companies about building pilot plants.
Read more: First Method for Continuous Purification of Valuable Antibodies
The Latest on: Drug production
[google_news title=”” keyword=”Drug production” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug production
- NCB busts drug manufacturing labs in Gujarat, Rajasthan; contrabands worth Rs 300 crore seizedon April 27, 2024 at 7:27 am
At least seven persons involved in the drug cartel have been apprehended and the kingpin has been identified who will soon be arrested, the NCB said.
- To live in drug-tainted housing, or to live without shelter?on April 27, 2024 at 6:31 am
Experts remain divided on the science of drug contamination. Have evacuations and stalled shelter projects done more harm than good in Snohomish County?
- AI Supercharges Fentanyl Production And Distribution, Study Findson April 27, 2024 at 4:00 am
One need not be a world leader in AI-assisted pharmacology to start illicit drug production. You simply need to understand the key precursor chemicals, AI and synthesize.
- Limestone Correctional warden due in court May 7 on drug chargeson April 26, 2024 at 4:16 pm
More information about the multi-count drug arrest of the warden of Limestone Correctional Facility has been released, court documents show.
- Scientists discover a new signaling pathway and design a novel drug for liver fibrosison April 26, 2024 at 9:25 am
A healthy liver filters all the blood in your body, breaks down toxins and digests fats. It produces collagen to repair damaged cells when the liver is injured. However, a liver can produce too much ...
- Why the obesity drug market is about to get a lot more crowdedon April 26, 2024 at 7:48 am
The U.S. is set to see a surge in obesity drug introductions over the next five years. Here’s a rundown of the potential entrants.
- Mexico’s chief detective apologizes for saying his country is the ‘champion’ of fentanyl productionon April 25, 2024 at 5:13 pm
The head of Mexico’s detective service has apologized for saying his country is “the champion” of fentanyl and meth production.
- A Proven Model to Combat U.S. Drug Shortageson April 25, 2024 at 5:05 am
Drug shortages continue to plague the United States. In many ways, the problem is the result of deficiencies in the current pharma market. But a model for addressing this problem is showing that it ...
- Shortages of generic drugs can’t be blamed solely on group purchasing organizationson April 25, 2024 at 1:31 am
The dominance of group purchasing organizations (GPOs) is often cited as a cause of generic drug shortages. The problem is more complicated than that.
- Malaria is still killing people in Kenya, but a vaccine and local drug production may helpon April 25, 2024 at 12:17 am
Malaria is still a significant public health challenge in Kenya, but an important pilot of the world’s first malaria vaccine may help.
via Bing News